The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
U.S. Department of Health and Human Services
  • YouTube
  • HRSA eNews
  • Print this
  • Email this

Program Assessments

Providing support to patients who need a potentially life-saving bone marrow or umbilical cord blood transplant is the overarching goal of the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129, and the Stem Cell Therapeutic and Research Reauthorization Act of 2010, Public Law 111-264. This goal is accomplished by:

  • Helping more patients receive a transplant from an unrelated donor or cord blood unit
  • Improving health outcomes for patients receiving a transplant

Performance Standards and Measurements describe how the contractors accomplish these goals for each component of the C.W. Bill Young Cell Transplantation Program. Each contractor reports its performance measurements to the U.S. Health Resources and Services Administration (HRSA).

The Program Assessment Rating Tool (PART) measures the performance of every Federal program. PART goals are evaluated by the U.S. Office of Management and Budget.

Bone Marrow or Cord Blood Transplantation

Learn about who may need a bone marrow or cord blood transplant, what a transplant is, and how the blood-forming cells are donated.